SCHEMBL18753675

SCHEMBL18753675

O=C(c1ccc(NSc2cccc3cccnc23)cc1)N1CCN(Cc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ PRKAA2 P54646 3/20 0.49
▸ PRKAB2 O43741 2/20 0.49
▸ PRKAG1 P54619 2/20 0.49
▸ PRKAA1 Q13131 2/20 0.49
▸ PRKAG3 Q9UGI9 2/20 0.49
▸ PRKAG2 Q9UGJ0 2/20 0.49
▸ PRKAB1 Q9Y478 2/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PKLR P30613 2/20 0.49
▸ PKM P14618 2/20 0.49
▸ SIGMAR1 Q99720 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21650911 0.96 GRIN2B (0.48) NPC1KDM4EALDH1A1PRKAA2PRKAB2
SCHEMBL18753736 0.94 SMN1; SMN2 (0.48) NPC1KDM4EALDH1A1PRKAA2PRKAB2
SCHEMBL18753314 0.92 PKLR (0.51) KDM4EALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL20192393 0.92 PRKAA2 (0.51) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
SCHEMBL18753474 0.92 PKLR (0.51) KDM4EALDH1A1MEN1KMT2APKLR
SCHEMBL18754024 0.90 ALDH1A1 (0.53) NPC1KDM4EALDH1A1PRKAA2MEN1
SCHEMBL18753961 0.90 PKLR (0.47) KDM4EALDH1A1PRKAA2PRKAB2PRKAG1
SCHEMBL20192355 0.90 PKLR (0.52) KDM4EALDH1A1KMT2ATSHRL3MBTL1
SCHEMBL21650900 0.89 LSS (0.48) KDM4EALDH1A1KMT2ATSHRL3MBTL1
SCHEMBL18754032 0.89 PKLR (0.46) KDM4EALDH1A1PRKAA2PKLRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback